Health Care (CNBC)
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
1 day 13 hours ago
Checkout news23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memo
In a memo to employees on Tuesday, 23andMe CEO Anne Wojcicki said the company will search for new directors.
1 day 18 hours ago
Checkout newsHealthy Returns: How competitive can Roche be in the weight loss drug market?
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
2 days 2 hours ago
Checkout newsFDA clears Apple's sleep apnea detection feature for use. Here's how it works
The U.S. Food and Drug Administration on Monday cleared Apple's new sleep apnea detection feature for use.
3 days 2 hours ago
Checkout newsDrugmakers bet billions that targeted radiation could become the next cancer breakthrough
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.
3 days 6 hours ago
Checkout newsPfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.
3 days 8 hours ago
Checkout newsBoar's Head indefinitely closes Virginia plant tied to deadly listeria outbreak, discontinues liverwurst
The company called the outbreak a "dark moment" in its history and apologized for the contamination of its liverwurst product, linked to the deaths of nine people.
6 days 2 hours ago
Checkout newsFlorida discourages use of mRNA Covid vaccines in older adults
In updated guidance to health care providers, Florida health officials advise that "non-mRNA Covid-19 vaccines and treatment" should be prioritized.
6 days 3 hours ago
Checkout newsModerna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027
Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.
1 week ago
Checkout newsGilead says its twice-yearly shot cut HIV infections by 96% in trial
The data sets the stage for likely approval of Gilead's lenacapavir for HIV prevention.
1 week ago
Checkout newsApple turning AirPods into hearing aids underscores effort to crack massive health market
Apple is using its newest AirPods Pro as a way to help break into the health industry, a potential $15 trillion market.
1 week ago
Checkout newsEli Lilly says it will invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily to increase production.
1 week ago
Checkout newsDigital health company Noom to offer compounded GLP-1 drug through new weight loss program
Digital health company Noom is offering compounded GLP-1 drugs to patients in new weight loss program
1 week ago
Checkout news'Economy class syndrome' is a medical issue that can happen on flights — no matter where you sit
Deep vein thrombosis can be a serious health issue that strikes at any time. But medium-to long-haul flights increase the risk of developing it.
1 week ago
Checkout newsThis government-backed startup is growing blood to help fight shortages
Safi Biotherapeutics, a government-backed startup, is growing blood in a lab to help fight shortages.
1 week 1 day ago
Checkout newsHealthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
A large swath of insured Americans could be eligible for a popular class of weight loss and diabetes drugs. Meanwhile, Apple announces new health features.
1 week 2 days ago
Checkout newsAstraZeneca shares fall 5% on disappointing lung cancer drug trial results
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.
1 week 2 days ago
Checkout newsAlzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncertainties, diagnostic test requirements and regular brain scans, among others.
1 week 4 days ago
Checkout newsHealthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile, Abbott launches its first over-the-counter continuous glucose monitor in U.S.
2 weeks ago
Checkout newsAbbott launches its first over-the-counter continuous glucose monitor in the U.S.
Abbott Laboratories announced Lingo, its first over-the-counter continuous glucose monitor, is available in the U.S.
2 weeks ago
Checkout newsIn 51 U.S. states are published
2197
Companies
652
Counties
1266
Cities
The 5 newest Companies
1014 N Pines Rd #102, Spokane Valley, WA 99206
206 2nd St, Wenatchee, WA 98801
22725 AL-181, Fairhope, AL 36532
70 S Washington Ave, Bergenfield, New Jersey 07621
2907 E State St, Trenton, NJ 08619
Other Companies
27 Lincoln Ave, City of Orange, NJ 07050
6580 FM78, San Antonio, TX 78244
204 N 1st St, Abbotsford, WI 54405
121 W Main St, Grafton, WV 26354
5959 Arlington Ave, Riverside, California 92504